
Misook Yu
Supervisory Patent Examiner (ID: 1022, Phone: (571)272-0839 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1641 |
| Total Applications | 859 |
| Issued Applications | 261 |
| Pending Applications | 201 |
| Abandoned Applications | 403 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1065757
[patent_doc_number] => 06846883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-25
[patent_title] => 'Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/873409
[patent_app_country] => US
[patent_app_date] => 2001-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7123
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/846/06846883.pdf
[firstpage_image] =>[orig_patent_app_number] => 09873409
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/873409 | Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof | Jun 4, 2001 | Issued |
Array
(
[id] => 5889031
[patent_doc_number] => 20020013262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'Method of inhibiting metastatic dissemination using desmopressin'
[patent_app_type] => new
[patent_app_number] => 09/875671
[patent_app_country] => US
[patent_app_date] => 2001-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4872
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20020013262.pdf
[firstpage_image] =>[orig_patent_app_number] => 09875671
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/875671 | Method of inhibiting metastatic dissemination using desmopressin | Jun 4, 2001 | Issued |
Array
(
[id] => 6429336
[patent_doc_number] => 20020127228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'PGT and apoptosis'
[patent_app_type] => new
[patent_app_number] => 09/871721
[patent_app_country] => US
[patent_app_date] => 2001-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7676
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127228.pdf
[firstpage_image] =>[orig_patent_app_number] => 09871721
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/871721 | PGT and apoptosis | Jun 3, 2001 | Abandoned |
Array
(
[id] => 5935979
[patent_doc_number] => 20020061543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence'
[patent_app_type] => new
[patent_app_number] => 09/873637
[patent_app_country] => US
[patent_app_date] => 2001-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10942
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061543.pdf
[firstpage_image] =>[orig_patent_app_number] => 09873637
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/873637 | c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence | Jun 3, 2001 | Issued |
Array
(
[id] => 6548571
[patent_doc_number] => 20020137906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Tumor suppressor pathway in C. elegans'
[patent_app_type] => new
[patent_app_number] => 09/872523
[patent_app_country] => US
[patent_app_date] => 2001-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17631
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137906.pdf
[firstpage_image] =>[orig_patent_app_number] => 09872523
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/872523 | Tumor suppressor pathway in C. elegans | May 31, 2001 | Abandoned |
Array
(
[id] => 7325129
[patent_doc_number] => 20040138135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Therapeutic compounds for ovarian cancer'
[patent_app_type] => new
[patent_app_number] => 09/870216
[patent_app_country] => US
[patent_app_date] => 2001-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19513
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20040138135.pdf
[firstpage_image] =>[orig_patent_app_number] => 09870216
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/870216 | Therapeutic compounds for ovarian cancer | May 29, 2001 | Abandoned |
Array
(
[id] => 6129415
[patent_doc_number] => 20020076713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Mutant Plk protein and gene encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/866590
[patent_app_country] => US
[patent_app_date] => 2001-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6501
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20020076713.pdf
[firstpage_image] =>[orig_patent_app_number] => 09866590
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/866590 | Mutant Plk protein and gene encoding the same | May 29, 2001 | Issued |
Array
(
[id] => 6467054
[patent_doc_number] => 20020150954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways'
[patent_app_type] => new
[patent_app_number] => 09/870379
[patent_app_country] => US
[patent_app_date] => 2001-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 23069
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20020150954.pdf
[firstpage_image] =>[orig_patent_app_number] => 09870379
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/870379 | Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways | May 29, 2001 | Issued |
Array
(
[id] => 6829759
[patent_doc_number] => 20030180817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Method of diagnosing, monitoring, staging, imaging and treating colon cancer'
[patent_app_type] => new
[patent_app_number] => 09/867034
[patent_app_country] => US
[patent_app_date] => 2001-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26266
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180817.pdf
[firstpage_image] =>[orig_patent_app_number] => 09867034
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/867034 | Method of diagnosing, monitoring, staging, imaging and treating colon cancer | May 28, 2001 | Abandoned |
Array
(
[id] => 6290106
[patent_doc_number] => 20020055157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-09
[patent_title] => '22244 and 8701, novel human dehydrogenases and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/870130
[patent_app_country] => US
[patent_app_date] => 2001-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 43110
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20020055157.pdf
[firstpage_image] =>[orig_patent_app_number] => 09870130
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/870130 | 22244 and 8701, novel human dehydrogenases and uses thereof | May 28, 2001 | Abandoned |
Array
(
[id] => 6829649
[patent_doc_number] => 20030180707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Reagents and methods for identifying and modulating expression of genes regulated by retinoids'
[patent_app_type] => new
[patent_app_number] => 09/865879
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8939
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180707.pdf
[firstpage_image] =>[orig_patent_app_number] => 09865879
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/865879 | Reagents and methods for identifying and modulating expression of genes regulated by retinoids | May 24, 2001 | Issued |
Array
(
[id] => 6095239
[patent_doc_number] => 20020051771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-02
[patent_title] => 'Apoptotic entities for use in treatment of T-cell-mediated and inflammatory disorders'
[patent_app_type] => new
[patent_app_number] => 09/866488
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4611
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20020051771.pdf
[firstpage_image] =>[orig_patent_app_number] => 09866488
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/866488 | Apoptotic entities for use in treatment of T-cell-mediated and inflammatory disorders | May 24, 2001 | Abandoned |
Array
(
[id] => 6730669
[patent_doc_number] => 20030186859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => '58224, a novel helicase family member and uses therefor'
[patent_app_type] => new
[patent_app_number] => 09/861165
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 44525
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186859.pdf
[firstpage_image] =>[orig_patent_app_number] => 09861165
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/861165 | 58224, a novel helicase family member and uses therefor | May 17, 2001 | Abandoned |
Array
(
[id] => 5985098
[patent_doc_number] => 20020098190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Compositions and methods for treating tumors bearing HMFG and CEA antigens'
[patent_app_type] => new
[patent_app_number] => 09/861294
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 27765
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20020098190.pdf
[firstpage_image] =>[orig_patent_app_number] => 09861294
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/861294 | Compositions and methods for treating tumors bearing HMFG and CEA antigens | May 16, 2001 | Abandoned |
Array
(
[id] => 6132008
[patent_doc_number] => 20020077463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => '16105, a novel protein human phosphatase and uses therefor'
[patent_app_type] => new
[patent_app_number] => 09/860351
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 35396
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20020077463.pdf
[firstpage_image] =>[orig_patent_app_number] => 09860351
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/860351 | 16105, a novel protein human phosphatase and uses therefor | May 16, 2001 | Abandoned |
Array
(
[id] => 6080486
[patent_doc_number] => 20020081637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents'
[patent_app_type] => new
[patent_app_number] => 09/858891
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6835
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20020081637.pdf
[firstpage_image] =>[orig_patent_app_number] => 09858891
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/858891 | Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents | May 16, 2001 | Issued |
Array
(
[id] => 826770
[patent_doc_number] => 07402434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-22
[patent_title] => 'Splice choice antagonists as therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 09/849967
[patent_app_country] => US
[patent_app_date] => 2001-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 23116
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/402/07402434.pdf
[firstpage_image] =>[orig_patent_app_number] => 09849967
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/849967 | Splice choice antagonists as therapeutic agents | May 7, 2001 | Issued |
| 09/830942 | Cloning and characterization of two m-rna transcription factors | May 1, 2001 | Abandoned |
Array
(
[id] => 694601
[patent_doc_number] => 07071004
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-07-04
[patent_title] => '14094, a novel human trypsin family member and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/846512
[patent_app_country] => US
[patent_app_date] => 2001-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 48810
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/071/07071004.pdf
[firstpage_image] =>[orig_patent_app_number] => 09846512
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/846512 | 14094, a novel human trypsin family member and uses thereof | Apr 30, 2001 | Issued |
Array
(
[id] => 6749889
[patent_doc_number] => 20030044409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens'
[patent_app_type] => new
[patent_app_number] => 09/847102
[patent_app_country] => US
[patent_app_date] => 2001-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10639
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044409.pdf
[firstpage_image] =>[orig_patent_app_number] => 09847102
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/847102 | Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens | Apr 30, 2001 | Abandoned |